Pneumonitis and eosinophilia induced by ethambutol

Journal of Allergy and Clinical Immunology

Volumn 100, Issue 5, 1997, Pages 712-713

  Takami, Akiyoshi ^a,b   Nakao, Shinji ^b   Asakura, Hidesaku ^b   Yamazaki, Hirohito ^a   Mizuhashi, Keiichi ^a   Matsuda, Tamotsu ^b   Mizushima, Noriaki ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; INTERLEUKIN 5; ISONIAZID; LYMPHOKINE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

AGED; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; DRUG INDUCED DISEASE; EOSINOPHILIA; HUMAN; MALE; MYCOBACTERIUM TUBERCULOSIS; PNEUMONIA; PRIORITY JOURNAL; TREATMENT OUTCOME; TUBERCULOSIS; TUBERCULOUS LYMPHADENITIS;

EID: 0030691924     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70178-7     Document Type: Article

References (5)

1. Lees AW, Smith AJ, Tyrrell WF, Fallon RJ. Toxicity from rifampicin plus isoniazid and rifampicin plus ethambutol therapy. Tubercle 1971;52:182-90.
2. Girling DJ. Adverse effects of antituberculosis drugs. Drugs 1982;23:56-74.
3. Wong CF, Yew WW. Ethambutol-induced neutropenia and eosinophilia. Chest 1994;106:1638-9.
4. Dent LA, Strath M, Mellor AL, Sanderson CJ. Eosinophilia in transgenic mice expressing interleukin-5. J Exp Med 1990;172:1425-31.
5. Snavely SR, Hodges GR. The neurotoxicity of antibacterial agents. Ann Intern Med 1984;101:92-104.